Bio-Rad Laboratories Gross Margin 2010-2022 | BIO.B

Current and historical gross margin for Bio-Rad Laboratories (BIO.B) over the last 10 years. The current gross profit margin for Bio-Rad Laboratories as of March 31, 2022 is %.
Bio-Rad Laboratories Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-03-31 $2.90B $1.64B 56.77%
2021-12-31 $2.92B $1.64B 56.14%
2021-09-30 $2.98B $1.70B 57.05%
2021-06-30 $2.88B $1.63B 56.60%
2021-03-31 $2.70B $1.52B 56.31%
2020-12-31 $2.55B $1.44B 56.44%
2020-09-30 $2.38B $1.31B 54.92%
2020-06-30 $2.29B $1.25B 54.36%
2020-03-31 $2.33B $1.26B 54.16%
2019-12-31 $2.31B $1.26B 54.37%
2019-09-30 $2.31B $1.26B 54.66%
2019-06-30 $2.29B $1.24B 54.17%
2019-03-31 $2.29B $1.23B 53.84%
2018-12-31 $2.29B $1.22B 53.45%
2018-09-30 $2.29B $1.24B 53.88%
2018-06-30 $2.28B $1.25B 54.66%
2018-03-31 $2.21B $1.22B 55.11%
2017-12-31 $2.16B $1.19B 54.95%
2017-09-30 $2.11B $1.16B 54.83%
2017-06-30 $2.09B $1.14B 54.53%
2017-03-31 $2.10B $1.14B 54.55%
2016-12-31 $2.07B $1.14B 55.03%
2016-09-30 $2.07B $1.13B 54.74%
2016-06-30 $2.03B $1.12B 55.00%
2016-03-31 $2.02B $1.12B 55.30%
2015-12-31 $2.02B $1.12B 55.54%
2015-09-30 $2.05B $1.13B 55.20%
2015-06-30 $2.11B $1.16B 54.84%
2015-03-31 $2.14B $1.17B 54.84%
2014-12-31 $2.18B $1.18B 54.16%
2014-09-30 $2.18B $1.18B 54.31%
2014-06-30 $2.15B $1.18B 54.74%
2014-03-31 $2.14B $1.18B 55.18%
2013-12-31 $2.13B $1.18B 55.23%
2013-09-30 $2.10B $1.17B 55.61%
2013-06-30 $2.10B $1.16B 55.29%
2013-03-31 $2.08B $1.15B 55.11%
2012-12-31 $2.07B $1.16B 55.87%
2012-09-30 $2.05B $1.15B 56.38%
2012-06-30 $2.06B $1.18B 56.96%
2012-03-31 $2.08B $1.18B 56.87%
2011-12-31 $2.07B $1.18B 56.85%
2011-09-30 $2.06B $1.17B 56.71%
2011-06-30 $2.01B $1.14B 56.48%
2011-03-31 $1.96B $1.11B 56.76%
2010-12-31 $1.93B $1.09B 56.59%
2010-09-30 $1.89B $1.06B 56.06%
2010-06-30 $1.88B $1.05B 56.12%
2010-03-31 $1.84B $1.03B 55.96%
2009-12-31 $1.78B $1.00B 56.05%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.121B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00